PRKN and diabetic cardiomyopathy: Their results also suggested that inhibiting mitophagy down-regulation mediated by SIRT3-FoxO3A-Parkin signaling could play a role in the pathogenesis of diabetic cardiomyopathy (Yu et al., 2017).